European Biotech Acquisition Corp. | Uncategorized | Business Contracts

Sponsor Support Agreement, dated October 17, 2022 by and among Sponsor, EBAC and Oculis (Filed With SEC on October 17, 2022)

Business Combination Agreement, dated October 17, 2022 by and among EBAC and Oculis SA (Filed With SEC on October 17, 2022)

Description of Securities (Filed With SEC on March 31, 2022)

A Letter Agreement, dated March 15, 2021, among the Company and its officers, certain of its directors and LSP Sponsor EBAC B.V (Filed With SEC on March 18, 2021)

Indemnity Agreement, dated March 15, 2021, between the Company and Eduardo Bravo Fernandez de Araoz (Filed With SEC on March 18, 2021)

Indemnity Agreement, dated March 15, 2021, between the Company and Gerrit Volkert Henri Doeksen (Filed With SEC on March 18, 2021)

Indemnity Agreement, dated March 15, 2021, between the Company and Mark Wegter (Filed With SEC on March 18, 2021)

Indemnity Agreement, dated March 15, 2021, between the Company and Martijn Kleijwegt (Filed With SEC on March 18, 2021)

Indemnity Agreement, dated March 15, 2021, between the Company and Koen Sintnicolaas (Filed With SEC on March 18, 2021)

Indemnity Agreement, dated March 15, 2021, between the Company and Onno van de Stolpe (Filed With SEC on March 18, 2021)

Indemnity Agreement, dated March 18, 2021, between the Company and Mohammad Sohail Fazeli (Filed With SEC on March 18, 2021)

A Letter Agreement, dated March 18, 2021, among the Company, Mohammad Sohail Fazeli and LSP Sponsor EBAC B.V (Filed With SEC on March 18, 2021)

Specimen Unit Certificate (Filed With SEC on March 4, 2021)

Form of Indemnity Agreement (Filed With SEC on March 4, 2021)

Form of Letter Agreement between the Registrant, the Sponsor and each director and executive officer of the Registrant (Filed With SEC on March 4, 2021)

European Biotech Acquisition Corp. (40) | Uncategorized (15)